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Abstract 
Key points 
• Malfunction of the cystic fibrosis transmembrane conductance regulator (CFTR), a 
gated pathway for chloride movement, causes the common life-shortening genetic 
disease cystic fibrosis (CF). 
• Towards the development of a sheep model of CF, we have investigated the function 
of sheep CFTR. 
• We found that sheep CFTR was noticeably more active than human CFTR, while the 
most common CF mutation, F508del, had reduced impact on sheep CFTR function. 
• Our results demonstrate that subtle changes in protein structure have marked effects 
on CFTR function and the consequences of the CF mutation F508del. 
Abstract 
Cross-species comparative studies are a powerful approach to understanding the epithelial Cl− channel cystic fibrosis 
transmembrane conductance regulator (CFTR), which is defective in the genetic disease cystic fibrosis (CF). Here, we 
investigate the single-channel behaviour of ovine CFTR and the impact of the most common CF mutation, F508del-CFTR, 
using excised inside-out membrane patches from transiently transfected CHO cells. Like human CFTR, ovine CFTR formed 
a weakly inwardly rectifying Cl− channel regulated by PKA-dependent phosphorylation, inhibited by the open-channel 
blocker glibenclamide. However, for three reasons, ovine CFTR was noticeably more active than human CFTR. First, single-
channel conductance was increased. Second, open probability was augmented because the frequency and duration of channel 
openings were increased. Third, with enhanced affinity and efficacy, ATP more strongly stimulated ovine CFTR channel 
gating. Consistent with these data, the CFTR modulator phloxine B failed to potentiate ovine CFTR Cl− currents. Similar to 
its impact on human CFTR, the F508del mutation caused a temperature-sensitive folding defect, which disrupted ovine 
CFTR protein processing and reduced membrane stability. However, the F508del mutation had reduced impact on ovine 
CFTR channel gating in contrast to its marked effects on human CFTR. We conclude that ovine CFTR forms a regulated Cl− 
channel with enhanced conductance and ATP-dependent channel gating. This phylogenetic analysis of CFTR structure and 
function demonstrates that subtle changes in structure have pronounced effects on channel function and the consequences of 
the CF mutation F508del. 
 
Abbreviations 
ABC transporter ATP-binding cassette transporter 
CF cystic fibrosis 
CFTR cystic fibrosis transmembrane conductance regulator 
I single-channel current amplitude 
IBI interburst interval 
ICL intracellular loop 
M transmembrane segment 
MBD mean burst duration 
MSD membrane-spanning domain 
NBD nucleotide-binding domain 
Po open probability 
PKA protein kinase A 
 
The cystic fibrosis transmembrane conductance regulator (CFTR; ABCC7; Riordan et al. 1989) is the ATP-binding cassette 
(ABC) transporter that functions as a ligand-gated anion channel (Gadsby et al. 2006). Located predominantly in the apical 
membrane of epithelia lining ducts and tubes throughout the body, CFTR plays a pivotal role in transepithelial ion transport 
as its dysfunction in the genetic disease cystic fibrosis (CF) testifies (Welsh et al. 2001). 
To understand better the diverse physiological roles CFTR plays in different organs and learn how CFTR dysfunction causes 
organ-level disease, a variety of CF animal models have been developed. Soon after the identification of the CFTR gene, 
CFTR knockout mice were generated and used to evaluate innovative therapies for CF (for review, see Wilke et al. 2011). 
However, anatomical and physiological differences between humans and mice have driven the search for new animal models 
of CF, leading to the development of CFTR knockout pigs, ferrets and rats (Rogers et al. 2008; Sun et al. 2010; Tuggle et al. 
2014). These new animal models have provided important insight into the pathogenesis of CF lung disease (Pezzulo et al. 
2012) and CF-related diabetes (Olivier et al. 2012). Nevertheless, for several reasons, sheep remain an attractive species to 
use to develop a large animal model of CF. First, ovine CFTR shows a high degree of sequence conservation with human 
CFTR (91% identity and 95% similarity at the amino acid level) with the pattern of ovine CFTR gene expression during 
development mirroring that of human CFTR (Tebbutt et al. 1995). Second, the sheep lung exhibits a high degree of 
anatomical and functional similarity with the human lung (Alcorn et al. 1981; Olver & Robinson, 1986). Third, the sheep 
lung has proved to be a valuable model system to evaluate experimental therapeutics for CF lung disease, including small-
molecules (Coote et al. 2009) and gene therapy (McLachlan et al. 2011). Finally, the technology to successfully clone sheep 
from somatic cells has existed for some time (Campbell et al. 1996) and could be used to generate a CF sheep. 
In this study, our goal was to establish the potential utility of ovine CFTR as a model of human CFTR. We investigated the 
behaviour of ovine CFTR and the consequences of the most common CF mutation, F508del-CFTR on the processing, 
plasma membrane stability and function of ovine CFTR. To address our aims, we assembled a full-length cDNA encoding 
ovine CFTR, introduced the F508del mutation by site-directed mutagenesis, transiently expressed these cDNAs in Chinese 
hamster ovary (CHO) cells and studied single-channels and macroscopic currents using excised inside-out membrane 
patches. We discovered that ovine CFTR forms a regulated Cl− channel with enhanced conductance and ATP-dependent 
gating compared to human CFTR. In contrast to its effects on human CFTR, the F508del mutation had reduced impact on 
ovine CFTR channel gating, but disrupted protein processing and membrane stability. By demonstrating that wide-ranging 
effects on single-channel behaviour can result from subtle changes in protein structure our results inform the phylogenetic 
analysis of CFTR structure and function.  
Methods 
Assembly of a full-length ovine CFTR cDNA 
The full-length ovine CFTR cDNA was assembled in 2005 by joining the partial cDNAs α, A, B, C, D′, F and G as described 
in Table 1 of Tebbutt et al. (1995). Each fragment was excised from the pCRII cloning vector with relevant restriction 
enzymes, ligated onto an adjacent fragment and cloned into pUC18, before further assembly of the construct as follows: 
fragments F and G were joined first and sequenced, revealing a frameshift mutation that was subsequently repaired by 
substitution of a 217 bp MscI-BlpI wild-type fragment; fragments C and D′ were joined and sequenced; fragments CD′ and 
FG were ligated and cloned into pUC18. Fragments A and B were ligated and cloned into pUC18 and then joined to 
fragment α in the same vector. Sequencing revealed several mutations in fragment A, which were corrected by site-directed 
mutagenesis with the exception of F229L, a polymorphism found in some wild-type CFTR homologues (e.g. murine). 
Segments αAB were then combined with CD′FG and cloned into pcDNA3.1zeo. The cryptic bacterial promoter in exon 6 of 
CFTR was abolished by site-directed mutagenesis (using the primer 5′ CGT CAG AAA TGA TTG AAA ACA TCC AAT 
CAG TTA AGGC 3′) to generate T933C (equivalent to T936C in human CFTR; Cheng et al. 1990). The F508del mutation 
was introduced into this construct using the QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent, Santa 
Clara, CA, USA) and the following primer 5′ GAA CCA TTA AAG ATA ACA TCA TCG GTG TTT CCT ATG ATG AAT 
ATA G 3′. 
Table 1. Open and closed time constants of ovine CFTR Cl− channels 
 Human Ovine 
 Wild-type F508del Wild-type F508del 
1. Time constants (τO1, fast open time constant; τO2, slow open time 
constant; τC1, fast closed time constant; τC3, slow closed time constant) were 
derived from the fitting of one- or two-component exponential functions to 
open and closed time histograms using the maximum likelihood method as 
described in the Methods. Area under curve indicates the proportion of the 
total open or closed time distribution that corresponds to the different time 
constants. Events per minute represents the number of transitions between 
the open and closed states within 1 min. The total time analysed for human 
and ovine CFTR is shown and in each patch approximately 5000 events were 
analysed for wild-type human and ovine CFTR, 700 events for F508del 
human CFTR and 3000 events for F508del ovine CFTR. Values are means ± 
SEM of n observations; *P < 0.05 vs. human CFTR; †P < 0.05 vs. F508del 
human CFTR. Measurements were made at 37°C in the presence of the 
catalytic subunit of PKA (75 nM) and ATP (1 mM) in the intracellular 
solution; voltage was –50 mV and there was a large Cl− concentration 
gradient across the membrane ([Cl−]internal = 147 mM; [Cl−]external = 10 mM). All 
Table 1. Open and closed time constants of ovine CFTR Cl− channels 
 Human Ovine 
 Wild-type F508del Wild-type F508del 
F508del-CFTR data analysed were acquired before channel rundown 
commenced (Wang et al. 2014). 
τO1 (ms) — 4.7 ± 1.9 — 2.2 ± 0.2 
τO2 (ms) 36.6 ± 2.1 46.9 ± 7.6 55.5 ± 4.0* 75.7 ± 5.9† 
τC1 (ms) 3.0 ± 0.1 3.9 ± 0.4 1.7 ± 0.2* 1.5 ± 0.1† 
τC3 (ms) 109 ± 7 1584 ± 212 87 ± 7* 239 ± 49† 
Area under 
curve τO1 
— 0.46 ± 0.06 — 0.24 ± 0.06 
Area under 
curve τO2 
1 0.54 ± 0.06 1 0.76 ± 0.06 
Area under 
curve τC1 




0.33 ± 0.01 0.32 ± 0.05 0.19 ± 0.02* 0.16 ± 0.01
† 
Events per 
minute 1462 ± 88 216 ± 44 1506 ± 130 1407 ± 147
† 
Total time (s) 1029 948 1952 779 
n 6 5 13 6 
Cells and CFTR expression systems 
Chinese hamster ovary K1 (CHO-K1) and human embryonic kidney 293 (HEK-293) cells were cultured as previously 
described (Graham et al. 1977; Lansdell et al. 1998a). For biochemical studies, human and ovine CFTR were transiently 
expressed in HEK-293 cells using calcium phosphate (Leir & Harris, 2011), whereas for single-channel studies they were 
transiently expressed with green fluorescent protein (GFP) in CHO-K1 cells using the Lipofectamine Plus® system (Life 
Technologies Ltd, Paisley, UK). Thirty-six to sixty hours after transfection, GFP-expressing CHO-K1 cells were selected for 
study using the patch-clamp technique. To investigate the single-channel behaviour of F508del ovine CFTR, transiently 
transfected CHO cells were incubated at 27°C for 24–72 h prior to use to deliver the mutant protein to the cell surface 
(Denning et al. 1992; Aleksandrov et al. 2012). For comparison, we studied human CFTR Cl− channels in excised inside-out 
membrane patches from CHO cells transiently and mouse mammary epithelial cells (C127 cells) stably expressing wild-type 
and F508del human CFTR. The single-channel behaviour of wild-type human CFTR in excised membrane patches from 
different mammalian cell lines is equivalent (Lansdell et al. 1998a; Chen et al. 2009). 
Western blotting 
To assess the expression of ovine CFTR protein, we used Western blotting. HEK-293 cells were lysed 72 h post-transfection 
using NET Buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, 1% Triton X-100, pH 7.5) supplemented with protease 
inhibitors (Sigma, St. Louis, MO, USA; P8340) and 100 mM phenylmethylsulfonyl fluoride. Lysates were then passed 
through a 25 G needle, incubated on ice for 15 min and cleared by centrifugation (16,000 g at 4°C for 15 min). SDS loading 
buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 12.5 mM EDTA, pH 6.8) with 5% β-mercaptoethanol was added to each 
lysate, followed by incubation at 55°C for 15 min. Lysates were then resolved on 3%/6% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) gels and transferred to Immobilon membranes (Millipore, Billerica, MA, 
USA). Membranes were blocked in Tris-buffered saline (TBS)–Tween (TBST) containing 5% milk and then probed 
overnight at 4°C using the mouse anti-CFTR monoclonal antibody (596), which recognizes nucleotide-binding domain 2 
(NBD2) of human and ovine CFTR (Cui et al. 2007; a generous gift of T. Jensen and J. R. Riordan (University of North 
Carolina, USA) and Cystic Fibrosis Foundation Therapeutics (Bethesda, MD, USA)) diluted 1:2000 in TBST containing 1% 
milk. Membranes were washed with TBST, probed at room temperature with polyclonal goat anti-mouse-HRP (Dako, 
Carpinteria, CA, USA) diluted 1:10,000 in 1% milk TBST for 2 h and washed with TBST before developing using enhanced 
chemiluminescence (ECL) Western Blotting Substrate (Pierce, Rockford, IL, USA; 32106). 
Patch-clamp experiments 
CFTR Cl− channels were recorded in excised inside-out membrane patches using an Axopatch 200B patch-clamp amplifier 
and pCLAMP software (versions 6.0 and 9.2) (all from Molecular Devices, Union City, CA, USA) as described previously 
(Sheppard & Robinson, 1997). The pipette (extracellular) solution contained (mM): 140 N-methyl-D-glucamine (NMDG), 
140 aspartic acid, 5 CaCl2, 2 MgSO4 and 10 N-tris[hydroxymethyl]methyl-2-aminoethanesulphonic acid (Tes), adjusted to 
pH 7.3 with Tris ([Cl−], 10 mM). The bath (intracellular) solution contained (mM): 140 NMDG, 3 MgCl2, 1 CsEGTA and 10 
Tes, adjusted to pH 7.3 with HCl ([Cl−], 147 mM; free [Ca2+], <10−8 M) and was maintained at 37°C. 
Within 5 min of membrane patch excision, we added the catalytic subunit of protein kinase A (PKA, 75 nM) and ATP (1 
mM) to the intracellular solution to activate CFTR Cl− channels. To minimize channel rundown, we added PKA to all 
intracellular solutions, maintained the ATP concentration at ≥0.3 mM and clamped voltage at −50 mV. The effects of CFTR 
modulators on ovine CFTR Cl− channels were tested by addition to the intracellular solution in the continuous presence of 
ATP (1 mM) and PKA (75 nM). Because the effects of the CFTR potentiator phloxine B are only partially reversible (Cai & 
Sheppard, 2002), specific interventions were compared with the pre-intervention control period made with the same 
concentration of ATP and PKA, but without the test CFTR modulator. 
For single-channel studies, we used membrane patches containing ≤5 active channels (human CFTR, number of active 
channels (N) ≤4; F508del human CFTR, N = 1; ovine CFTR, N ≤ 4; F508del ovine CFTR, N ≤ 5); for all other studies, 
membrane patches contained large numbers of active channels. To determine channel number, we used the maximum 
number of simultaneous channel openings observed during the course of an experiment (for further information, see Cai et 
al. 2006). Using voltage ramp protocols, we acquired macroscopic current–voltage (I–V) relationships (Cai et al. 2003). To 
evaluate the plasma membrane stability of F508del ovine CFTR at 37°C, we calculated open probability (Po) values in 20 s 
intervals over a 10–15 min period, commencing Po measurements only after channels were fully activated. 
Single-channel currents were initially recorded on digital audiotape using a digital tape recorder (model DTR-1204, Bio-
Logic Science Instruments; Intracel Ltd., Royston, UK) at a bandwidth of 10 kHz. On playback, records were filtered with 
an eight-pole Bessel filter (model F-900C/9L8L, Frequency Devices Inc., Ottawa, IL, USA) at a corner frequency (fc) of 500 
Hz and acquired using a DigiData1320A interface (Molecular Devices, CA, USA) and pCLAMP software at sampling rates 
of 1.0 kHz (voltage ramp protocols), 2.5 kHz (time course studies) or 5 kHz (single-channel studies). 
To measure single-channel current amplitude (i), Gaussian distributions were fitted to current amplitude histograms; chord 
conductance was calculated as described by Cai et al. (2003). For Po and kinetic analyses, lists of open and closed times were 
created using a half-amplitude crossing criterion for event detection and dwell-time histograms constructed as previously 
described (Sheppard & Robinson, 1997); transitions <1 ms were excluded from the analysis (eight-pole Bessel filter rise 
time (T10–90) ∼0.73 ms at fc = 500 Hz). Histograms were fitted with one or more component exponential functions using the 
maximum likelihood method. To determine which component function fitted best, the log-likelihood ratio test was used and 
considered statistically significant at a value of 2.0 or greater (Winter et al. 1994). For wild-type human CFTR, time constant 
values were unaffected when data were filtered at fc = 1 kHz, digitized at 10 kHz and transitions <0.5 ms excluded from the 
analysis (T10–90 ∼0.34 ms) (data not shown). Burst analysis was performed as described by Cai et al. (2006) using a tc (the 
time that separates interburst closures from intraburst closures determined from closed time histograms (e.g. human CFTR, tc 
= 13.6 ± 0.4 ms (n = 6); ovine CFTR, tc = 8.9 ± 0.7 ms (n = 11) in the presence of 1 mM ATP). The mean interburst interval 
(TIBI) was calculated using the equation (Cai et al. 2003):  
• (1) 
where, Tb = (mean burst duration) × (open probability within a burst). Mean burst duration (TMBD) and open probability within 
a burst (Po(burst)) were determined directly from experimental data using pCLAMP software. Only membrane patches which 
contained a single active CFTR Cl− channel were used for burst and kinetic analyses. 
To calculate the voltage-dependent dissociation constant (Kd) for CFTR inhibition by glibenclamide, we used the equation:  
• (2) 
where, Kd(V) is the voltage-dependent dissociation constant at voltage V, and I and Io are current values in the presence and 
absence of drug, respectively. To determine the electrical distance across the membrane sensed by blocking ions, we used 
the equation (Woodhull, 1973):  
• (3) 
where z′ is the apparent valency of the blocking ion (defined as the actual valency of the blocking ion (z) multiplied by the 
electrical distance across the membrane experienced by the blocking ion (δ)) and F, R and T are the Faraday constant, gas 
constant and absolute temperature, respectively. For glibenclamide inhibition of CFTR, we assume a valency of −1 and a 
single binding site (Sheppard & Robinson, 1997). 
Some electrophysiology data for wild-type human CFTR in this paper are reproduced from previously published work 
(Sheppard & Robinson, 1997; Cai & Sheppard, 2002; Cai et al. 2003; Scott-Ward et al. 2007). In Figs 6C and 7E, the wild-
type human CFTR data are directly reproduced. In the remainder of the electrophysiology figures, the wild-type human 
CFTR data are a combination of new and old data. The contribution of previously published data to the total data set is 
indicated in the relevant figure legends. 
Reagents 
PKA purified from bovine heart was purchased from Calbiochem (Merck Chemicals Ltd., Nottingham, UK). All other 
chemicals were of reagent grade and supplied by the Sigma-Aldrich Company Ltd. (Gillingham, UK). ATP was dissolved in 
intracellular solution directly before each experiment. All other reagents were dissolved in DMSO and stored at −20°C. 
Immediately before use, stock solutions were diluted to achieve final concentrations and, where necessary, the pH of the 
intracellular solution was re-adjusted to pH 7.3 to avoid pH-dependent changes in CFTR function (Chen et al. 2009). DMSO 
did not affect CFTR activity (Sheppard & Robinson, 1997). 
Modelling 
Like that of human CFTR (Mornon et al. 2008), the three-dimensional model of the membrane-spanning domains (MSDs) 
and NBDs of ovine CFTR protein was constructed using as a template the Sav1866 three-dimensional structure in an 
outward-facing conformation (pdb code: 2hyd; Dawson & Locher, 2006). Based on new three-dimensional structures of 
ABC exporters (pdb codes: 3g5u, 3g60, 4ksb, 4f4c, 3wme, 3wmf, 3zdq, 4ayt, 4ayx, 4ayw, 4myc, 4mrn, 4mrp, 4mrr, 4mrs, 
4mrv and 3qf4), the alignment of the MSDs described in Mornon et al. (2008) was modified slightly (Mornon et al. 2015). 
The three-dimensional model of the MSD:NBD assembly of ovine CFTR was built using Modeller 9.10 (Martí-Renom et al. 
2000). It includes amino acids 65–648 (MSD1:NBD1), with the regulatory insertion (404–434), and amino acids 843–1448 
(MSD2:NBD2), with the linker insertion (1183–1203). The overall stereo-chemical quality of the model was assessed using 
PROCHECK (Laskowski et al. 1993). 
Statistics 
Results are expressed as means ± SEM of n observations. To test for differences between groups of data, we used Student's t 
test. Differences were considered statistically significant when P < 0.05. All tests were performed using SigmaStat™ 
(version 3.5; Systat Software Inc., Richmond, CA, USA). 
Ovine CFTR has augmented conductance and gating 
compared with human CFTR 
In this study, we investigated the single-channel behaviour of ovine CFTR in excised inside-out membrane patches from 
transiently transfected CHO cells. Figure 1A shows representative single-channel recordings of human and ovine CFTR 
following phosphorylation with PKA. Two important differences are apparent from visual inspection of these traces. First, 
the single-channel current amplitude (i) of ovine CFTR was larger than that of human CFTR (Fig. 1A and B). To quantify 
this difference, we measured single-channel current amplitude at negative voltages (Fig. 2A), where the i–V relationship is 
linear in the presence of a large Cl− concentration gradient (Fig. 2B) (Sheppard et al. 1993). At negative voltages, the single-
channel conductance of ovine CFTR (9.89 ± 0.14 pS; n = 13) was significantly greater than that of human CFTR (8.59 ± 
0.08; n = 10; P < 0.05) (Fig. 2C). 
 
Figure 1. The single-channel behaviour of ovine CFTR 
A, representative recordings show the single-channel activity of human and ovine CFTR in 
excised inside-out membrane patches from transiently transfected CHO cells. ATP (1 mM) 
and PKA (75 nM) were continuously present in the intracellular solution. Dotted lines 
indicate the closed channel state and downward deflections correspond to channel openings. 
Beneath each prolonged 10 s recording, the 2 s portions indicated by bars are shown on an 
expanded time scale. Unless otherwise indicated in this and subsequent figures, excised 
inside-out membrane patches were voltage clamped at –50 mV and there was a large Cl− 
concentration gradient across the membrane patch ([Cl−]internal = 147 mM; [Cl−]external = 10 mM). 
For the purpose of illustration, single-channel records were filtered at 500 Hz and digitized at 
5 kHz before file size was compressed by 5-fold data reduction. B–E, single-channel current 
amplitude (i), open probability (Po), mean burst duration (MBD) and interburst interval (IBI) 
of human and ovine CFTR for the experimental conditions described in A. Data are means ± 
SEM (human, i and Po, n = 10, MBD and IBI, n = 6; ovine, i and Po, n = 24, MBD and IBI, n 
= 13); *P < 0.05 vs. human CFTR. In B–E, some human CFTR data were originally 
published in Scott-Ward et al. (2007), copyright (2007) National Academy of Sciences, USA 
(i and Po, n = 5; MBD and IBI, n = 5); other human CFTR data are newly acquired using 
CHO cells expressing human CFTR. 
 
Figure 2. Single-channel conductance of ovine CFTR 
A, representative recordings show the single-channel activity of ovine CFTR in an excised 
inside-out membrane patch from a CHO cell at the indicated voltages. ATP (1 mM) and PKA 
(75 nM) were continuously present in the intracellular solution. Dotted lines indicate the 
closed channel state and downward deflections correspond to channel openings. B, single-
channel current–voltage (i–V) relationships of human and ovine CFTR. Data are means ± 
SEM (human, n = 10; ovine, n = 13); error bars are smaller than symbol size except where 
shown. The continuous lines are the fit of first order linear regression functions to mean data 
(r2 > 0.99). C, single-channel slope conductance (γ) of human and ovine CFTR determined 
from the slope of the i–V relationships in B; *P < 0.05 vs. human CFTR. In B and C, some 
human CFTR data were originally published in Scott-Ward et al. (2007), copyright (2007) 
National Academy of Sciences, USA (n = 5); other human CFTR data are newly acquired 
using CHO cells expressing human CFTR. 
Second, there was a difference in the pattern of channel gating. The gating behaviour of human CFTR is characterized by 
bursts of channel openings interrupted by brief flickery closures, separated by longer closures between bursts. Like human 
CFTR, the ovine CFTR Cl− channel exhibited a bursting pattern of channel activity (Fig. 1A). However, the mean burst 
duration (MBD) of ovine CFTR was 71% longer than that of human CFTR, while its interburst interval (IBI) was 34% 
shorter (Fig. 1D and E). As a result, the Po of ovine CFTR was 41% greater than that of human CFTR (Fig. 1C). 
To explore further the gating behaviour of ovine CFTR, we investigated gating kinetics using membrane patches that 
contained only a single active CFTR Cl− channel. For both human and ovine CFTR, open and closed time histograms were 
best fitted with one- and two-component exponential functions, respectively (Fig. 3A and B and Table 1). The two 
populations of channel closures, described by fast (τC1) and slow (τC3) closed time constants, represent the brief, flickery 
closures that interrupt channel openings and the prolonged closures, which separate one channel opening from the next. 
Consistent with the burst analysis (Fig. 1D and E), Fig. 3A and B and Table 1 suggest that the augmented Po of ovine CFTR 
is a consequence of a 51% lengthening of the open time constant (τO2) and a 20% reduction in the slow closed time constant 
(τC3). Figure 3A and B and Table 1 also reveal that the fast closed time constant (τC1) of ovine CFTR was 45% shorter than 
that of human CFTR. However, its share of the closed time distribution was 19% larger than that of human CFTR (Table 1). 
Thus, ovine CFTR has augmented conductance and gating compared to that of human CFTR. 
 
Figure 3. Dwell time histograms of ovine CFTR 
Representative dwell time histograms of human and ovine CFTR in the absence (A and B) 
and presence (C and D) of the F508del mutation. Data are from experiments in which the 
excised inside-out membrane patch from transiently transfected CHO cells (or stably 
transfected C127 cells expressing F508del human CFTR) contained only one active channel, 
studied in the presence of ATP (1 mM) and PKA (75 nM). The continuous lines are the fit of 
one- or two-component exponential functions to the data and the dotted lines show the 
individual components of these functions. The vertical dashed lines indicate the mean values 
of the open (τO1, τO2) and closed (τC1, τC3) time constants of human CFTR (A and B) and 
F508del human CFTR (C and D). Logarithmic x-axes with 10 bins decade−1 were used for 
dwell time histograms; note the changes in abscissa (C and D) and ordinate (C). 
ATP gates ovine CFTR with greater affinity and 
efficacy than human CFTR 
CFTR channel gating is tightly controlled by cycles of ATP binding and hydrolysis at the NBDs (Gadsby et al. 2006). 
Therefore, we speculated that the enhanced channel gating of ovine CFTR might reflect altered ATP affinity and/or efficacy. 
To test this idea, we examined the ATP dependence of channel gating using membrane patches containing ≤4 active 
channels. 
Figure 4A shows the effects of increasing the intracellular ATP concentration from 0.03 to 3 mM in the continuous presence 
of PKA (75 nM) on ovine CFTR, while Fig. 4B plots the relationship between ATP concentration and Po for human and 
ovine CFTR. By fitting Michaelis–Menten functions to mean data (Fig. 4B), we calculated values of KD (the ATP 
concentration required for half-maximal activity, which describes the apparent affinity of CFTR for ATP) and Po(max) (the 
maximum Po). For human CFTR, KD = 230 μM and Po(max) = 0.66 (r2 = 0.95), while for ovine CFTR, KD = 77 μM and Po(max) = 
0.70 (r2 = 0.93). These data suggest that ATP gates ovine CFTR with enhanced affinity and efficacy compared to human 
CFTR. 
 
Figure 4. The ATP dependence of ovine CFTR 
A, representative recordings show the activity of a single ovine CFTR Cl− channel in an 
excised inside-out membrane patch from a CHO cell at the indicated intracellular ATP 
concentrations. PKA (75 nM) was continuously present in the intracellular solution. Dotted 
lines indicate the closed channel state and downward deflections correspond to channel 
openings. B–G, relationship between ATP concentration and open probability (Po), interburst 
interval (IBI), mean burst duration (MBD), fast closed time constant (τC1), slow time constant 
(τC3) and open time constant (τO2) of human and ovine CFTR plotted using a logarithmic x-
axis. For ovine CFTR, data are from transiently transfected CHO cells, whereas human CFTR 
data are pooled from CHO cells transiently and C127 cells stably expressing human CFTR. 
Data are means ± SEM (Po, human, n = 4–16; ovine, n = 5–13; MBD, IBI, τC1, τC3 and τO2, 
human, n = 5–14; ovine, n = 4–12) from experiments where ≥2 (ovine) or ≥3 (human) ATP 
concentrations were tested in each membrane patch. In B, continuous lines are the fits of 
Michaelis–Menten functions to mean data. In B–G, some human CFTR data were originally 
published in Scott-Ward et al. (2007), copyright (2007) National Academy of Sciences, USA 
and Cai & Sheppard (2002), copyright the American Society for Biochemistry and Molecular 
Biology (n = 4); other human CFTR data are newly acquired using C127 cells stably 
expressing human CFTR. 
To understand further how ATP stimulates ovine CFTR channel gating, we investigated gating kinetics. For human CFTR, 
ATP modulates the duration of long closures separating bursts of channel openings, but has little or no effect on channel 
openings or the short closures that interrupt them (Winter et al. 1994). Like those of human CFTR, the long closures of 
ovine CFTR were strongly ATP dependent, whereas the short closures were ATP independent (Fig. 4C, E and F). Figure 4D 
and G demonstrates that ATP had little or no effect on channel openings of human CFTR, but increased the duration of those 
of ovine CFTR. As a result, at 3 mM ATP, the MBD and open time constant (τO2) of ovine CFTR were 82% and 79% longer 
than those of human CFTR (Fig. 4D and G). Taken together, the data demonstrate that ATP stimulates human CFTR by 
increasing the rate of channel opening only, whereas it stimulates ovine CFTR both by increasing the rate of channel 
opening and by slowing the rate of channel closure. 
Voltage dependence of ovine CFTR 
Human CFTR has a pseudo-linear I–V relationship, exhibiting weak inward rectification at large positive voltages (Cai et al. 
2003). To investigate whether ovine CFTR exhibits similar behaviour, we bathed excised inside-out membrane patches in 
symmetrical 147 mM Cl− solutions and recorded membrane currents over the voltage range ±100 mV using a voltage-ramp 
protocol (Fig. 5A). Under basal conditions, membrane currents were tiny (Fig. 5A). However, following the activation of 
ovine CFTR by PKA-dependent phosphorylation large membrane currents were observed (Fig. 5A). Figure 5B and C 
demonstrates that at negative voltages, the I–V relationship of ovine CFTR was linear, whereas at positive voltages, it 
exhibited weak inward rectification (Fig. 5C). The data also suggest that rectification is weaker for ovine CFTR than human 
CFTR (current at +100 mV: human, 74 ± 2% of that at −100 mV (n = 10) (Cai et al. 2003); ovine, 84 ± 2% of that at −100 
mV (n = 6); P < 0.01). 
 
Figure 5. The I–V relationship of ovine CFTR in the presence of 
symmetrical Cl−-rich solutions 
A, current traces from an excised inside-out membrane patch from a CHO cell expressing 
ovine CFTR. The recordings were made in the absence (middle) and presence (bottom) of 
ATP (1 mM) and PKA (75 nM) in the intracellular solution. The basal recording is the current 
in response to a single ramp of voltage with no active CFTR Cl− channels, whereas the 
recording in the presence of PKA and ATP is the average of 11 ramps of voltage. Holding 
voltage was –50 mV and the membrane patch was bathed in symmetrical 147 mM NMDGCl 
solutions. The voltage ramp protocol used is shown above the recordings and currents were 
acquired at a sampling rate of 1 kHz as described in Cai et al. (2003). B, I–V relationship 
constructed by subtracting the basal trace from the PKA and ATP trace shown in A. C, I–V 
relationship of ovine CFTR Cl− currents. Data are means ± SEM (n = 6) at each voltage 
calculated by expressing individual current values measured from –100 to +100 mV in 10 
mV increments as a percentage of the current value at –100 mV. Error bars are smaller than 
symbol size. The continuous line is the fit of a second order regression function to the data. 
The dotted line shows the predicted ohmic I–V relationship. 
To investigate further the inward rectification of ovine CFTR, we studied single Cl− channels. Figure 6A and B compares the 
activity of a single ovine CFTR Cl− channel at −50 mV and +50 mV using identical conditions to those employed to study 
ovine CFTR Cl− currents, while Fig. 6C and D quantifies changes in single-channel chord conductance and Po. Similar to the 
behaviour of human CFTR, the chord conductance of ovine CFTR decreased with membrane depolarization (e.g. −50 mV, γ 
= 13.76 ± 0.26 pS; +50 mV, γ = 11.66 ± 0.29 pS; n = 11; P < 0.05) (Fig. 6C). However, the decrease in Po of ovine CFTR at 
+50 mV, while small, was greater than that of human CFTR (human, 2%; ovine 13%; P = 0.03) (Fig. 6D). Reminiscent of 
human CFTR (Cai et al. 2003), visual inspection of single-channel records suggested that at +50 mV the duration of both 
bursts of channel openings and the intervening long closures were decreased in length (Fig. 6A). Thus, rectification of both 
human and ovine CFTR is caused by a reduction in i and changes in channel gating. 
 
Figure 6. The single-channel behaviour of ovine CFTR in symmetrical 
Cl−-rich solutions 
A, representative recordings of a single ovine CFTR Cl− channel at –50 mV (top) and +50 mV 
(bottom). The excised inside-out membrane patch from a CHO cell transiently expressing 
ovine CFTR was bathed in symmetrical 147 mM NMDGCl solutions and ATP (1 mM) and 
PKA (75 nM) were continuously present in the intracellular solution. Dotted lines indicate the 
closed channel state, while downward deflections at –50 mV and upward deflections at +50 
mV correspond to channel openings. B, current amplitude histograms of the single ovine 
CFTR Cl− channel shown in A; the closed channel amplitudes are shown on the left. The 
continuous lines represent the fit of Gaussian distributions to the data and the vertical dashed 
lines indicate the position of the open and closed channel levels at –50 mV. C, relationship 
between chord conductance and voltage for ovine CFTR. Data are means ± SEM (ovine, n = 
6–11). For comparison, equivalent data for human CFTR (©2003 Cai et al. Journal of 
General Physiology. 122:605–620. doi:10.1085/jgp.200308921) are shown as a dotted line. 
Chord conductance was calculated as described in the Methods. D, single-channel open 
probability (Po) of ovine CFTR at –50 and +50 mV. Data are means ± SEM (n = 9); *P < 
0.05 vs. ovine CFTR value at –50 mV. For comparison, Po values of human CFTR Cl− 
channels at –50 and +50 mV were 0.54 ± 0.03 and 0.53 ± 0.02, respectively (n = 6); P = 0.71. 
Pharmacology of ovine CFTR 
Previous studies have highlighted differences in the response of CFTR homologues to small-molecule CFTR modulators 
(e.g. Lansdell et al. 1998a; Stahl et al. 2012). We were therefore keen to explore the pharmacological profile of ovine CFTR, 
selecting for study the fluorescein derivative phloxine B, which potentiates robustly human CFTR (Cai & Sheppard, 2002), 
and the sulphonylurea drug glibenclamide, a widely-used open-channel blocker of human CFTR (Schultz et al. 1996; 
Sheppard & Robinson, 1997). 
Figure 7A and B shows the effects of phloxine B on ovine CFTR Cl− currents. In contrast to its potentiation of human CFTR, 
low micromolar concentrations of phloxine B (0.1–5 μM) were without effect or inhibited weakly ovine CFTR Cl− currents 
(Fig. 7B). However, elevated concentrations of phloxine B (≥10 μM) inhibited strongly both human and ovine CFTR (Fig. 
7B). 
 
Figure 7. Effects of phloxine B and glibenclamide on ovine CFTR Cl− 
currents 
A and C, representative time courses of ovine CFTR Cl− currents in excised inside-out 
membrane patches from CHO cells expressing ovine CFTR; voltage was –50 mV and there 
was a large Cl− concentration gradient across the membrane patch ([Cl−]internal = 147 mM; 
[Cl−]external = 10 mM). During the periods indicated by the bars, ATP (1 mM), PKA (75 nM), 
phloxine B (Phlx B, 0.5 and 1 μM) and glibenclamide (Glib, 50 μM) were present in the 
intracellular solution. For the purpose of illustration, the time courses have been inverted so 
that upward deflections represent inward current. B, effects of phloxine B concentration (0.1–
50 μM) on human and ovine CFTR. Values above the dashed line indicate CFTR potentiation, 
whereas values below the line denote CFTR inhibition. D, representative I–V relationships of 
ovine CFTR Cl− currents recorded in the absence and presence of glibenclamide (50 μM) 
using the experimental conditions described in C. E, relationship between the voltage-
dependent dissociation constant (Kd) and voltage for ovine CFTR inhibition by 
glibenclamide. In B and E, data are means ± SEM (phloxine B, n = 5–11; glibenclamide, n = 
5); the continuous line in E is the fit of a first order regression to Kd values over the range –
100 to 0 mV (r2 = 0.84). In B, some human CFTR data were originally published in Cai & 
Sheppard (2002), copyright the American Society for Biochemistry and Molecular Biology (n 
= 4–7); other human CFTR data are newly acquired using C127 cells stably expressing 
human CFTR. In E, equivalent human CFTR data were originally published in Sheppard & 
Robinson (1997) and shown as a dotted line. 
Figure 7C demonstrates that ovine CFTR Cl− currents were inhibited by glibenclamide (50 μM), albeit with reduced efficacy 
compared with human CFTR (human, Idrug/Icontrol = 31 ± 3% (n = 8); ovine, Idrug/Icontrol = 44 ± 2% (n = 9); P < 0.05). To 
investigate further glibenclamide inhibition of ovine CFTR, we examined the voltage dependence of channel block (Fig. 7D 
and E). Although glibenclamide inhibition of ovine CFTR was weaker than that of human CFTR (human, Kd(0 mV) = 16 ± 2 
μM; ovine CFTR, Kd(0 mV) = 42 ± 12 μM (n = 5); P < 0.05), there was no difference in the electrical distance across the 
membrane sensed by glibenclamide between human and ovine CFTR (human CFTR, z′ = 0.25 ± 0.05; ovine CFTR, z′ = 0.31 
± 0.05 (n = 5) measured from the inside of the membrane; P < 0.44). Thus, the pharmacological profile of ovine CFTR 
shows similarities to, but also differences from, that of human CFTR. 
Impact of the F508del mutation on the ovine CFTR Cl− 
channel 
The most common CF mutation F508del is a temperature-sensitive folding mutant that prevents CFTR processing and 
intracellular transport, reduces CFTR stability at the plasma membrane and disrupts channel gating (Cheng et al. 1990; 
Dalemans et al. 1991; Denning et al. 1992; Lukacs et al. 1993). Because the ovine CFTR Cl− channel had greater activity 
than human CFTR, we were interested to learn the consequences of the F508del-CFTR mutation on ovine CFTR expression 
and function. 
Consistent with previous results (Aleksandrov et al. 2012), when expressed in HEK-293 cells, ovine CFTR generated band 
C, the mature, fully glycosylated form of CFTR protein, whereas F508del-ovine CFTR produced reduced levels of band C 
(Fig. 8). Based on these and other data (Aleksandrov et al. 2012), we incubated CHO cells expressing ovine F508del-CFTR 
at 27°C for 24–72 h before investigating its single-channel behaviour in excised inside-out membrane patches at 37°C. In 
marked contrast to its effects on human CFTR, the F508del mutation had less impact on ovine CFTR channel gating, but 
caused a small, albeit significant (P < 0.05), reduction in i (Fig. 9A and B). Figure 9C demonstrates that the F508del 
mutation reduced the Po of human CFTR by 89%, but that of ovine CFTR by only 32% to approximate the Po of wild-type 
human CFTR. To explain these results, we analysed gating kinetics. Figure 3C and D and Table 1 demonstrate that the 
F508del mutation introduced two populations of open times described by fast (τO1) and slow (τO2) open time constants in 
contrast to the single population of open times described by τO2 in human and ovine CFTR. For both human and ovine CFTR, 
the F508del mutation prolonged τO2 values (Table 1). However, the τO2 of F508del ovine CFTR was 61% longer than that of 
F508del human CFTR and its share of the open time distribution was 76%, whereas that of F508del human CFTR was only 
54% (Table 1). These results probably explain the different effects of the F508del mutation on the MBD of human and ovine 
CFTR, which was reduced by 36% and 12%, respectively (Fig. 9D). Figure 9E demonstrates that the F508del mutation had 
markedly different effects on IBI, increasing that of human CFTR 9-fold, but that of ovine CFTR only 2-fold. Consistent 
with these results, the slow closed time constant (τC3) of F508del ovine CFTR was 85% shorter than that of F508del human 
CFTR, but its share of the closed time distribution was half that of F508del human CFTR (Fig. 3C and D and Table 1). Thus, 
different impacts on the rate of channel opening predominantly explain the varying severity of the F508del mutation on the 
gating behaviour of human and ovine CFTR. 
 
Figure 8. Processing of wild-type and F508del ovine CFTR 
A, representative Western blot of total protein extracts from HEK-293 cells transiently 
expressing the indicated CFTR constructs (ov F508del, F508del ovine CFTR) lysed 72 h 
post-transfection. Lysates from untransfected HEK-293 cells (HEK) were used as a control. 
CFTR was detected with the mouse anti-CFTR monoclonal antibody (596), which recognizes 
a region of NBD2 conserved between human and ovine CFTR (amino acids 1204–1211) (Cui 
et al. 2007). Arrows indicate the positions of the band B (immature) and C (mature) forms of 
CFTR and the position of molecular weight markers is indicated. B, quantification of CFTR 
expression. The amount of CFTR protein present in the mature form (band C) is expressed as 
a percentage of total CFTR protein (%CFTR protein processed = [band C/(bands B + C)] × 
100). Data are means ± SD (n = 2). 
 
Figure 9. The single-channel activity of F508del ovine CFTR 
A, representative single-channel recordings of F508del human CFTR and F508del ovine 
CFTR in excised inside-out membrane patches from C127 and CHO cells. ATP (1 mM) and 
PKA (75 nM) were continuously present in the intracellular solution; temperature was 37°C. 
Dotted lines indicate the closed channel state and downward deflections correspond to 
channel openings. B–E, single-channel current amplitude (i), open probability (Po), mean 
burst duration (MBD) and interburst interval (IBI) of wild-type and F508del human and 
ovine CFTR Cl− channels. For ovine CFTR, data are from CHO cells transiently expressing 
CFTR constructs, whereas for wild-type human CFTR results are pooled from both 
transiently expressing CHO and stably expressing C127 cells (cf. human CFTR data in Fig. 
1), and for F508del human CFTR data are from stably expressing C127 cells. Data are means 
± SEM (wild-type human, i and Po, n = 23, MBD and IBI, n = 14; F508del human, i and Po, n 
= 5, MBD and IBI, n = 5; wild-type ovine, i and Po, n = 24, MBD and IBI, n = 13; F508del 
ovine, i and Po, n = 8, MBD and IBI, n = 6); *P < 0.05 vs. wild-type human CFTR; †P < 0.05 
vs. wild-type ovine CFTR. In B–E, some wild-type human CFTR data were originally 
published in Scott-Ward et al. (2007), copyright (2007) National Academy of Sciences, USA 
and Cai & Sheppard (2002), copyright the American Society for Biochemistry and Molecular 
Biology (n = 12); other human CFTR data are newly acquired using CHO and C127 cells; 
none of the F508del human CFTR data have previously been published. 
Accelerated channel rundown at 37°C is indicative of the reduced plasma membrane stability of F508del human CFTR (e.g. 
Schultz et al. 1999). However, the observation that F508del chicken CFTR is stable at 37°C (Aleksandrov et al. 2012) 
suggests that there are cross-species differences in the impact of the F508del mutation on CFTR plasma membrane stability. 
To test the effects of the F508del mutation on the plasma membrane stability of ovine CFTR, we analysed the duration of 
F508del ovine CFTR Cl− channel activity in excised inside-out membrane patches at 37°C in the continuous presence of 
PKA (75 nM) and ATP (1 mM). Figure 10 shows a representative prolonged recording of F508del ovine CFTR commenced 
following complete channel activation and its corresponding Po time course. Over the 14 min recording, channel activity was 
progressively lost, with Po declining from ∼0.4 to ∼0.1 (Fig. 10). Taken together, the data suggest that the F508del mutation 
alters the processing, plasma membrane stability and channel gating of ovine CFTR, but that its impact is less severe than on 
human CFTR. 
 
Figure 10. The single-channel activity of F508del ovine CFTR exhibits 
thermo-instability 
A and B, representative single-channel recording (A) and corresponding open probability (Po) 
time course (B) of F508del ovine CFTR in an excised inside-out membrane patch from a 
CHO cell commenced following full channel activation. ATP (1 mM) and PKA (75 nM) were 
continuously present in the intracellular solution; temperature was 37°C. In A, the 2 s long 
recordings labelled 1–4 indicated by the bars are displayed on an expanded time scale 
beneath the current recording. Arrows and dotted lines indicate the closed channel state and 
downward deflections correspond to channel openings. For the purpose of illustration, the 
single-channel record was filtered at 500 Hz and digitized at 5 kHz before file size was 
compressed by 50-fold data reduction. In B, Po values were calculated for each 20 s time 
interval. Similar results were observed in 7 other experiments. 
Jump to…  
Discussion 
In this study, we investigated the single-channel behaviour of ovine CFTR and the impact of the most common CF mutation 
F508del. Our data demonstrate that ovine CFTR is a more active Cl− channel than human CFTR because it has enhanced 
conductance and ATP-dependent channel gating. They also show that the F508del mutation has modest effects on ovine 
CFTR channel gating, but disrupts protein processing and membrane stability. Given the high degree of amino acid 
similarity between human and ovine CFTR, the magnitude of these functional differences is surprising. 
In previous work, Aleksandrov et al. (2012) demonstrated that recombinant ovine CFTR forms a regulated Cl− channel with 
conductance and Po similar to human CFTR when reconstituted into planar phospholipid bilayers. The reasons for the 
differences between the data acquired by Aleksandrov et al. (2012) and ourselves are not known. However, it is important to 
emphasize that the two studies used different experimental techniques and conditions. Moreover, our ovine CFTR construct 
contained the polymorphism F229L, whereas that used by Aleksandrov et al. (2012) had green fluorescent protein fused to 
its C-terminus. Irrespective of these differences, both studies draw important conclusions about the function of CFTR 
homologues. Below, we compare and contrast the behaviour of ovine CFTR with that of human CFTR. 
Using the relationship ICFTR = N × i × Po (where ICFTR is the macroscopic CFTR Cl− current, N is the number of CFTR Cl− 
channels in the plasma membrane, i is the current that flows through an individual CFTR Cl− channel, and Po is the 
probability that an individual CFTR channel is open) and the data in Fig. 1B and C, we can calculate the amount of Cl− 
current that passes through a single CFTR Cl− channel in 1 s (Valkenier et al. 2014). For wild-type human CFTR, Cl− 
transport per second is 2.0 × 106, whereas for wild-type ovine CFTR it is 3.5 × 106. These data suggest that ovine CFTR 
transports 1.5 times more Cl− per second than human CFTR. While it remains plausible that this difference is a consequence 
of heterologous expression of recombinant ovine CFTR, the present data and other results (Price et al. 1996; Scott-Ward et 
al. 2007; Dong et al. 2012) argue that amino acid sequence differences are responsible for the functional differences 
observed between CFTR homologues. Thus, our data raise the possibility that native ovine CFTR Cl− channels in ovine 
epithelial cells might be more active than their human CFTR counterparts. Perhaps this might reflect metabolic differences 
between humans and sheep. Alternatively, the demands of ruminant digestion might necessitate that ovine CFTR is more 
active than human CFTR. Future studies should investigate the behaviour of native ovine CFTR Cl− channels and their 
physiological roles. 
The single-channel behaviour of several recombinant CFTR homologues has been investigated. In all cases, CFTR 
expression generated Cl−-selective channels regulated by cAMP-dependent phosphorylation (Hanrahan et al. 1993; Price et 
al. 1996; Lansdell et al. 1998a; Ostedgaard et al. 2007; Demmers et al. 2010; Aleksandrov et al. 2012; present study). 
Allowing for experimental differences, single-channel conductance varies between species, decreasing in the rank order 
chicken >> rabbit > ovine ≥ Xenopus > human = possum > porcine > murine ≥ shark (Hanrahan et al. 1993; Price et al. 
1996; Lansdell et al. 1998a; Ostedgaard et al. 2007; Demmers et al. 2010; Aleksandrov et al. 2012; present study). These 
data raise the possibility that metabolic differences might directly or indirectly influence single-channel conductance. 
Previous work demonstrates that arginine residues act as fixed positive charges within the intra- and extracellular vestibules 
of the CFTR pore, playing an important role in maximizing the rate of Cl− flow (Smith et al. 2001; Gong & Linsdell, 2003; 
St Aubin & Linsdell, 2006; Zhou et al. 2010). To understand better why ovine CFTR has a higher single-channel 
conductance than human CFTR, we generated a molecular model of ovine CFTR based on the atomic-resolution structure of 
the ABC transporter Sav1866 in an outward-facing configuration and previous molecular models of human CFTR (Dawson 
& Locher, 2006; Serohijos et al. 2008; Mornon et al. 2008) (Fig. 11). Analysis of this molecular model suggests that there 
are no clear differences in the architecture of the CFTR pore between human and ovine CFTR (Fig. 11). First, it is doubtful 
whether A872V (seventh transmembrane segment; M7) and I982V (M9), the only two amino acids that are different 
between human and ovine CFTR within the pore-lining sequence, substantially affect pore properties. Second, the string of 
amino acid changes in the fourth extracellular loop (human, L884GNTP888; ovine, F884PKIL888) is probably too far from 
the pore to alter directly single-channel conductance (see also Zhou & Linsdell, 2009). Third, the model suggests that the 
sequence polymorphism F229L (M4) is unlikely to affect single-channel conductance because it is located in a 
transmembrane segment distant from the CFTR pore (Mornon et al. 2009; Norimatsu et al. 2012a) (Fig. 11). Based on recent 
studies of human CFTR (Mornon et al. 2015), future studies using molecular dynamics might elucidate the structural basis 
of the different pore properties exhibited by human and ovine CFTR. 
 
Figure 11. Molecular model of ovine CFTR 
Left, ribbon representation of the ovine CFTR MSD:NBD assembly modelled using as a 
template Sav1866 in an outward-facing conformation (pdb code: 2hyd). Atoms where amino 
acids differ between human and ovine CFTR are shown with spheres and the ATP molecules 
are coloured yellow. The grey shading represents the position of the membrane bilayer. 
Positions discussed in the text are highlighted. Right, orthogonal view of the CFTR pore, 
viewed from the extracellular side of the membrane. 
The gating behaviour of a few recombinant CFTR homologues has been examined. Interestingly, a common characteristic of 
ovine, porcine and the sub-conductance state (O1) of murine CFTR is the prolonged duration of open-channel bursts 
compared with that of human CFTR (Lansdell et al. 1998b; Scott-Ward et al. 2007; Ostedgaard et al. 2007; present study). 
Visual inspection of single-channel recordings suggests that Xenopus and shark CFTR have brief channel openings, whereas 
those of chicken CFTR are markedly prolonged (Hanrahan et al. 1993; Price et al. 1996; Aleksandrov et al. 2012). 
Phylogenetic analysis of these data suggests that with the exception of human CFTR, CFTRs from eutherian mammals have 
prolonged channel openings compared with other species. 
The present results demonstrate that ATP more strongly stimulates ovine CFTR than human CFTR. The data suggest that 
ovine CFTR has a higher apparent ATP affinity and ATP more strongly stimulates ovine CFTR by both increasing the 
opening rate and decreasing the closing rate. Using the ATP-driven NBD dimerization model of CFTR channel gating 
(Vergani et al. 2005; Csanády et al. 2010), the reduced IBI of ovine CFTR suggests that the energy barrier for NBD 
dimerization in ovine CFTR is less than that of human CFTR. Moreover, once the ovine CFTR NBD1:NBD2 dimer forms, it 
has greater stability than that of human CFTR. Increased stability of the ovine CFTR NBD1:NBD2 dimer might result from 
tighter binding or slower hydrolysis of ATP at the canonical ATP binding site (site 2), where ATP binding initiates channel 
opening and ATP hydrolysis leads promptly to channel closure (Gadsby et al. 2006). Alternatively, using the energetic 
coupling model of CFTR channel gating (Jih et al. 2012), the prolonged open time of ovine CFTR might be explained by the 
stabilization of a posthydrolytic open state leading to decoupling of the gating cycle from the ATP hydrolysis cycle. 
As for the CFTR pore, analysis of the molecular model of ovine CFTR identified no clear differences between human and 
ovine CFTR within the critical motifs that form the two ATP-binding sites (Figs 11 and 12). Instead, the amino acid 
differences between human and ovine CFTR (9%) are mostly concentrated in sequence fragments that play (or are likely to 
play) regulatory roles. These regions include the N-terminus, the regulatory insertion of NBD1, the regulatory domain, the 
linker region between MSD2 and NBD2 and the C-terminus (Fig. 12). Interestingly, in several of these regions, the 
differences lead to the presence of additional serine and threonine residues in ovine CFTR. 
 
Figure 12. Alignment of the sequences of human and ovine CFTR 
Amino acid sequence alignments of human (Riordan et al. 1989) and ovine (Tebbutt et al. 
1995) CFTR are shown. Above the sequence alignments are the predicted secondary 
structures of CFTR based on the alignment of its sequence with that of Sav1866 (Mornon et 
al. 2008), whose three-dimensional structure (Dawson & Locher, 2006) was used to construct 
the models of CFTR's MSD:NBD assembly. Amino acids that are identical between human 
and ovine CFTR are shown as white letters on a black background. Regions which are not 
included in the ovine CFTR model, because of the absence of suitable templates, are shaded 
grey (N-terminus, regulatory (R) domain and C-terminus). 
Cross-species differences in the molecular pharmacology of CFTR have important implications for drug development. Our 
observation that low micromolar concentrations of the fluorescein derivative phloxine B, an efficacious CFTR potentiator 
(Cai & Sheppard, 2002; Cai et al. 2006), were without effect on ovine CFTR Cl− currents suggests that ovine CFTR might be 
insensitive to CFTR potentiators. These data are reminiscent of the action of CFTR potentiators on murine CFTR, which is 
unresponsive to pyrophosphate (Lansdell et al. 1998a), phloxine B (Z. Cai & D. N. Sheppard, unpublished observations) and 
ivacaftor (Van Goor et al. 2009). Building on these data, we previously demonstrated that transfer of both NBDs of murine 
CFTR to human CFTR renders chimeric CFTR Cl− channels insensitive to potentiation by pyrophosphate (Scott-Ward et al. 
2007). Given that both murine and ovine CFTR have prolonged channel openings and both are insensitive to potentiation by 
phloxine B, we speculate that sequence differences in the NBDs between human and ovine CFTR are responsible for the 
insensitivity of ovine CFTR to potentiation by phloxine B. 
The sulphonylurea drug glibenclamide, a widely used open-channel blocker of CFTR, inhibited ovine CFTR Cl− currents, 
albeit with reduced efficacy compared to human CFTR. Interestingly, previous work has identified species-dependent 
differences in the action of glibenclamide, the thiazolidinone, CFTRinh-172 (Ma et al. 2002; Kopeikin et al. 2010) and the 
glycine hydrazide, GlyH-101 (Muanprasat et al. 2004; Norimatsu et al. 2012b). When tested on recombinant CFTR 
homologues expressed in Xenopus oocytes (Stahl et al. 2012) or airway epithelia expressing endogenous CFTR (Liu et al. 
2007), GlyH-101 inhibited all homologues tested with the exception of murine CFTR, shark CFTR was insensitive to 
CFTRinh-172, and porcine CFTR was unaffected by glibenclamide (Liu et al. 2007; Stahl et al. 2012). To explain these 
differences in channel block, Stahl et al. (2012) speculated that subtle differences in the three-dimensional structure of the 
CFTR pore and local environment (e.g. hydrophobicity and charge) in the vicinity of drug-binding sites might be 
responsible. Based on the interaction of glibenclamide with molecular models of CFTR (Dalton et al. 2012) and our own 
modelling of ovine CFTR, the same explanation probably applies for differences in glibenclamide inhibition between human 
and ovine CFTR. 
In marked contrast to the impact of the F508del mutation on human CFTR (Cheng et al. 1990), Ostedgaard et al. (2007) 
found that the F508del-CFTR processing defect was less severe in porcine and murine CFTR. Subsequently, Aleksandrov et 
al. (2012) demonstrated that the F508del mutation disrupts to varying degrees the processing of mammalian CFTR 
homologues, whereas in non-mammalian species (e.g. frog and chicken) there was substantial maturation of F508del-CFTR 
protein at 37°C. Aleksandrov et al. (2012) further demonstrated that F508del chicken CFTR exhibits marked thermostability, 
remaining active at physiological temperatures, unlike F508del human CFTR, which deactivates very rapidly. The present 
results demonstrate that F508del ovine CFTR exhibits plasma membrane instability, characterized by time-dependent loss of 
channel activity in excised membrane patches at 37°C. However, the retention of F508del ovine CFTR channel activity 
beyond 10 min at 37°C suggests that it has less severe thermal instability than F508del human CFTR (Wang et al. 2011; Liu 
et al. 2012; Wang et al. 2014). 
Hypothesizing that structural differences between human and chicken CFTR account for the thermostability of F508del 
chicken CFTR, Aleksandrov et al. (2012) identified the F508del revertant mutation I539T (deCarvalho et al. 2002) and four 
proline residues at key positions within NBD1 (S422P, S434P, S492P, A534P). Of note, introducing the I539T revertant and 
the four proline mutations into F508del human CFTR restored protein processing, plasma membrane stability and channel 
function (Aleksandrov et al. 2012), suggesting that correction of NBD1 structure is sufficient to overcome the F508del 
mutation. By contrast, Ostedgaard et al. (2007) interpreted the species-dependent effects of F508del-CFTR on CFTR 
processing and channel function to suggest that these defects have different causes. This conclusion is supported by studies 
of human–murine CFTR chimeras which revealed that maturation of F508del-CFTR requires NBD1, whereas rescue of 
F508del-CFTR channel gating requires NBD1–MSD2 interactions (Dong et al. 2012). Consistent with these ideas, other 
studies (e.g. Mendoza et al. 2012; Rabeh et al. 2012) demonstrate that correction of NBD1 folding and the interaction of 
NBD1 with the fourth intracellular loop (ICL4) are required to suppress fully the processing and functional defects of 
F508del-CFTR. 
Similar to its effects on murine and porcine CFTR Cl− channels (Ostedgaard et al. 2007), the impact of the F508del mutation 
on the gating behaviour of ovine CFTR was modest. In all species tested, the F508del mutation prolonged the duration of 
long closures separating bursts of channel openings (Ostedgaard et al. 2007; present study), arguing that the mutation 
disrupts the formation of the NBD1:NBD2 dimer. Building on these data, Jih et al. (2011) demonstrated that F508del-CFTR 
destabilizes both the full and partial NBD1:NBD2 dimer configurations during channel gating. We speculate that our 
observation that F508 deletion generates two populations of open times is further evidence that the F508del mutation 
destabilizes CFTR channel gating. 
A notable feature of the present results is the reduction of i caused by the F508del mutation in ovine CFTR. Previous studies 
of F508del-CFTR and other CF mutations in the NBDs have found little or no evidence for effects of mutations on current 
flow through the CFTR pore unlike those in the MSDs (e.g. Sheppard et al. 1993, 1995). Given the location of F229 (M4, a 
transmembrane segment predicted not to line the CFTR pore; Fig. 11), we consider it unlikely that the F229L polymorphism 
is responsible for this change in conductance. Instead, the location of F508 at the interface between NBD1 and ICL4 raises 
the interesting possibility that under some circumstances F508del might destabilize the MSDs, reducing current flow through 
the CFTR pore. 
In conclusion, ovine CFTR has a high degree of amino acid sequence identity with human CFTR. However, for several 
reasons, ovine CFTR formed a Cl− channel with noticeably greater activity than that of human CFTR. First, the single-
channel conductance was increased. Second, ovine CFTR had a higher Po because the frequency and duration of channel 
openings were augmented. Third, with enhanced affinity and efficacy, ATP more strongly stimulated ovine CFTR channel 
gating. Similar to its impact on human CFTR, the F508del mutation disrupted the processing of ovine CFTR protein and 
reduced its plasma membrane stability. However, the mutation had less effect on ovine CFTR channel gating. These results 
have important implications for phylogenetic analysis of CFTR structure and function, arguing that subtle changes in 
structure have marked effects on channel function and the action of CF mutations. 
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